Manufacturer record
Anrose pharma 147: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Anrose pharma 147 (Himachal Pradesh) were declared Not of Standard Quality between February 2025 and June 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
2 records linked to Anrose pharma 147 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Rabeprazole Sodium Tablet IP | ATG5H619Mfg 2025-08 · Exp 2027-07 | Test For Assay (Content) Of Rabeprazole SodiumAssay | DelhiState lab | Jun 2026 |
| ACEGLO tablets Aceclofenac and Paracetamol Tablets | ATG4I7 87Mfg 2024-09 · Exp 2026-08 | MISBRANDED DRUG The drug product Aceclofenac and Paracetamol Tablets is official i.e. included in the Addendum 2024 to Indian Pharmacopoeia 2022 effective from 1st July, 2024-current edition of IP and as required as per Second Schesule of the Drugs and Cosmetics Act, 1940. The said drug product shall comply with the standards set out in the Indian Pharmacopoeia .But the designation IP in conjunction with the official title Aceclofenac and Paracetamol tablets on the label of the drug product was not menttioned as an indication that the drug product purports to comply with IP standards. Hence the drug product shall be deemed to be Misbranded Drug as per Secton 17 of Drugs and Cosmetics Act, as it is not labeled in the prescribed manner.Misbranded | State Lab Drugs Control Laboratory, TelanganaState lab | Feb 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.